Founders Capital Management (Texas)’s VanEck Biotech ETF BBH Stock Holding History

Founders Capital Management (Texas)’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.3K	Hold	100	–	–	0.01%	270
2026 Q1	$18.8K	Hold	100	–	–	0.01%	257
2025 Q4	$18.9K	Hold	100	–	–	0.01%	248
2025 Q3	$16.6K	Hold	100	–	–	0.01%	256
2025 Q2	$15.3K	Hold	100	–	–	0.01%	252
2025 Q1	$15.7K	Hold	100	–	–	0.01%	245
2024 Q4	$15.7K	Hold	100	–	–	0.01%	248
2024 Q3	$17.7K	Hold	100	–	–	0.01%	247
2024 Q2	$16.8K	Hold	100	–	–	0.01%	249
2024 Q1	$16.6K	Hold	100	–	–	0.01%	248
2023 Q4	$16.5K	Hold	100	–	–	0.01%	249
2023 Q3	$15.6K	Hold	100	–	–	0.01%	251
2023 Q2	$15.6K	Hold	100	–	–	0.01%	266
2023 Q1	$16K	Hold	100	–	–	0.01%	264
2022 Q4	$16K	Hold	100	–	–	0.01%	251
2022 Q3	$14K	Hold	100	–	–	0.01%	259
2022 Q2	$15K	Buy	+100	New	+$14.9K	0.01%	262

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Founders Capital Management (Texas)'s BBH Position: Q2 2026 in Review

Founders Capital Management (Texas) held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 100 shares worth $20.3K. The position accounts for 0.01% of the portfolio, ranked #270.

Founders Capital Management (Texas) first reported a position in BBH in Q2 2022 and has held it in 17 quarters since. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Founders Capital Management (Texas) held 100 shares of VanEck Biotech ETF worth $20.3K as of Q2 2026.
Founders Capital Management (Texas) left its VanEck Biotech ETF share count unchanged in Q2 2026.
VanEck Biotech ETF made up 0.01% of Founders Capital Management (Texas)'s portfolio in Q2 2026, its #270 holding.
Founders Capital Management (Texas) first reported a position in VanEck Biotech ETF in Q2 2022 and has held it in 17 quarters since.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Founders Capital Management (Texas)'s 13F filing for Q2 2026, filed 21 Jul 2026.